Colgate-Palmolive 8-K Details Operations, Financials, Debt Instruments
Ticker: CL · Form: 8-K · Filed: 2024-01-26T00:00:00.000Z
Sentiment: neutral
Topics: debt, financial-condition, corporate-governance
TL;DR
**Colgate-Palmolive filed an 8-K on Jan 26, detailing financial operations and various notes due between 2026 and 2039.**
AI Summary
Colgate-Palmolive Company filed an 8-K on January 26, 2024, to report the results of operations and financial condition, along with financial statements and exhibits. This filing specifically mentions various debt instruments, including 0.500% Notes due 2026, 0.300% Notes due 2029, 0.875% Notes due 2039, and 1.375% Notes due 2034, all registered on the New York Stock Exchange. This matters to investors because it provides transparency into the company's financial health and debt structure, which can impact future earnings and dividend capacity.
Why It Matters
This filing provides a snapshot of Colgate-Palmolive's financial status and debt obligations, crucial for investors to assess the company's stability and future growth prospects.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information and does not indicate any immediate new risks, but rather provides transparency on existing financial instruments.
Analyst Insight
A smart investor would review the full financial statements and exhibits referenced in this 8-K to gain a comprehensive understanding of Colgate-Palmolive's financial health and debt management strategy, especially considering the various interest rates and maturity dates of its notes.
Key Numbers
- 0.500% — Interest Rate (Notes due 2026)
- 0.300% — Interest Rate (Notes due 2029)
- 0.875% — Interest Rate (Notes due 2039)
- 1.375% — Interest Rate (Notes due 2034)
- 2026 — Maturity Year (0.500% Notes)
- 2029 — Maturity Year (0.300% Notes)
- 2034 — Maturity Year (1.375% Notes)
- 2039 — Maturity Year (0.875% Notes)
Key Players & Entities
- COLGATE-PALMOLIVE COMPANY (company) — registrant
- New York Stock Exchange (company) — exchange where securities are registered
- $1.00 (dollar_amount) — par value of Common Stock
Forward-Looking Statements
- Colgate-Palmolive will continue to manage its debt obligations effectively, given the staggered maturity dates of its notes. (COLGATE-PALMOLIVE COMPANY) — high confidence, target: 2039
FAQ
What is the earliest maturity date for the notes mentioned in this 8-K filing?
The earliest maturity date for the notes mentioned is 2026, corresponding to the 0.500% Notes due 2026.
What is the par value of Colgate-Palmolive Company's Common Stock as stated in the filing?
The par value of Colgate-Palmolive Company's Common Stock is $1.00 per share, as stated in the filing.
Which exchange are Colgate-Palmolive Company's securities registered on?
Colgate-Palmolive Company's securities, including Common Stock and various Notes, are registered on the New York Stock Exchange.
What is the highest interest rate among the notes listed in this filing?
The highest interest rate among the notes listed is 1.375%, for the Notes due 2034.
What is the purpose of this 8-K filing by Colgate-Palmolive Company?
The purpose of this 8-K filing, dated January 26, 2024, is to report on the results of operations and financial condition, and to include financial statements and exhibits, as per Item Information.
Filing Stats: 588 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-01-26 08:00:22
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value CL New York Stock Exchang
Filing Documents
- a53887925.htm (8-K) — 34KB
- a53887925ex99.htm (EX-99) — 1275KB
- 0001157523-24-000119.txt ( ) — 1548KB
- cl-20240126.xsd (EX-101.SCH) — 5KB
- cl-20240126_def.xml (EX-101.DEF) — 18KB
- cl-20240126_lab.xml (EX-101.LAB) — 28KB
- cl-20240126_pre.xml (EX-101.PRE) — 21KB
- a53887925_htm.xml (XML) — 9KB
02
Item 2.02. Results of Operations and Financial Condition. On January 26, 2024, Colgate-Palmolive Company (the "Company") issued a press release announcing its earnings for the quarter and year ended December 31, 2023. This press release is attached as Exhibit 99 and is incorporated herein by reference. The information in Item 2.02 of this Current Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
01
Item 9.01.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits . The following exhibits are filed with this document: Exhibit Number Description 99 Press release, dated January 26, 2024, issued by Colgate-Palmolive Company 104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document) EXHIBIT INDEX Exhibit Number Description 99 Press release, dated January 26, 2024, issued by Colgate-Palmolive Company 104 Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COLGATE-PALMOLIVE COMPANY Date: January 26, 2024 By: /s/ Stanley J. Sutula III Name: Stanley J. Sutula III Title: Chief Financial Officer